Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

XCounter AB to join Artemis Imaging GmbH on the development of an innovative 3D Breast CT system

XCounter AB (publ) (AIM: XCT), a technology leader in the development of photon counting detector and tomosynthesis-based 3D medical imaging, announced it is working with Artemis Imaging GmbH, a spinoff of the University of Erlangen's Institute of Medical Physics, on the development of an innovative 3D Breast CT system. The new device may have the potential to offer more comprehensive and higher quality breast scanning facilitating earlier detection of breast cancer, the most common form of cancer found in women.

Artemis Imaging GmbH, under the leadership of Prof. Willi Kalender, has substantial expertise and a proven track record in CT physics, system and applications development. It intends to develop, validate, clinically test and commercialize a low-dose, high-resolution breast CT scanner using the XCounter digital direct conversion solid state detector technology.

The new device will offer multiple views of the breast, while XCounter's photon counting technology will increase the overall quality of imaging.

Prof. Willi Kalender, CEO of Artemis Imaging GmbH stated: "We selected the XCounter photon counting technology because we believe it meets the requirements for a revolutionary new dedicated breast CT system which combines the highest image quality with the lowest
radiation dose to the patient."

Mikael Strindlund, CEO of XCounter commented:

"Today's announcement is further validation, by world-renown experts, of our leading photon counting solid state detectors and its potential to assist in the earlier identification of one of the most common forms of cancer."

XCounter's technology includes recently acquired AJAT technologies and XCounter's photon
counting technology. Artemis Imaging GmbH aims to qualify the technology as soon as it becomes available; a first detector has already been ordered for evaluation.

Source: XCounter AB